46)
Mizuki Horiuchi, Soichiro Moriyama, Yukiko Takahata, Tetsuya Aiba and
Yuji Kurosaki:
Effects of peritoneal dialysis on pharmacotherapy: A deductive pharmacokinetic-model approach to predict drug concentration profiles in plasma and peritoneal fluid.
Drug Metab. Pharmacokinet., 29 (2), 154-161 (2014 Apr).
y2012z
45)
Ayumi Masuda, Yuko Goto, Yuji Kurosaki and Tetsuya Aiba:
In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats.
J. Pharm. Sci., 101 (7), 2449-2456 (2012 Jul).
44)
•è—E“ñA•x‰ª‰À‹vAŽO“c’q•¶A–k‘º‰À‹vF
i‘àj‘—§‘åŠw‚É‚¨‚¯‚éu’·Šú‰Û‘茤‹†‹y‚уAƒhƒoƒ“ƒXƒg‹³ˆçƒvƒƒOƒ‰ƒ€v‚ÌŒ»ó [Development of advanced educational programs including research programs for undergraduate students in National Universities: the facts in 2010].C
Yakugaku Zasshi, 132 (3), 351-356 (2012 Mar).
43)
Junichi Kusaba, Noriko Kajikawa, Hiromu Kawasaki, Yuji Kurosaki and Tetsuya Aiba:
Comparative study on altered hepatic metabolism of CYP3A substrates in rats with glycerol-induced acute renal failure.
Biopharm. Drug Dispos., 33 (1), 22-29 (2012 Jan).
41)
Akemi Ogasawara, Yoshiki Murakami, Nobumasa Yakushiji, Fuminori Ohsawa,
Jun-ichi Kusaba, Tetsuya Aiba, Yuji Kurosaki and Hiroki Kakuta:
Pharmacokinetic properties of newly synthesized retinoid X receptor agonist possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats.
Drug Develop. Ind. Pharm., 37 (9), 1060-1067 (2011 Sep).
40)
Satoshi Ueshima, Tetsuya Aiba, Tomoaki Sato, Hisashi Matsunaga, Yuji Kurosaki, Yoko Ohtsuka, Toshiaki Sendo:
Empirical approach for improved estimation of unbound serum concentrations of valproic acid in epileptic infants by considering their physical development.
Biol. Pharm. Bull., 34 (1) 108-113 (2011 Jan).
y2010z
39)
Atsuko Ishikawa, Kentaro Kono, Rie Sakae, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Altered electrolyte handling of the choroid plexus in rats with glycerol-induced acute renal failure.
Biopharm. Drug Dispos., 31 (8-9), 455-463 (2010 Nov).
38)
Naomi Iihara, Kiyo Suzuki, Yuji Kurosaki, Shushi Morita, Keizo Hori:
Factorial invariance of a questionnaire assessing medication beliefs in Japanese non-adherent groups.
Pharmacy World Sci., 32 (4), 432-439 (2010 Aug).
37)
Akihiro Tanaka, Tetsuya Aiba, Takashi Otsuka, Katsuya Suemaru, Tatsuya
Nishimiya, Tomoyoshi Inoue, Mitsuharu Murase, Yuji Kurosaki and Hiroaki
Araki:
Population pharmacokinetic analysis of vancomycin using serum cystatin-C as a marker of renal function.
Antimicrob. Agents Chemother., 54 (2), 778-782 (2010 Feb).
y2009z
36)
S. Ueshima, T. Aiba, N. Ishikawa, T. Sato, H. Kawasaki, Y. Kurosaki, Y.
Ohtsuka and T. Sendo:
Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
J. Clin. Pharm. Ther., 34 (4), 415-422 (2009 Aug).
35)
Yuki Izuwa, Jun-ichi Kusaba, Mizuki Horiuchi, Tetsuya Aiba, Hiromu Kawasaki and Yuji Kurosaki:
Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure.
Drug Metab. Pharmacokinet., 24 (5), 451-457 (2009 May).
34)
Takashi Makita, Tetsuya Aiba, Yuki Izuwa, Yukiko Komori, Hiromu Kawasaki
and Yuji Kurosaki:
Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased.
Biopharm. Drug Dispos., 30 (1), 1-8 (2009 Jan).
32)
Rie Sakae, Atsuko Ishikawa, Tomoko Niso, Yukiko Komori, Tetsuya Aiba, Hiromu
Kawasaki and Yuji Kurosaki:
Decreased Lithium Disposition to Cerebrospinal Fluid in Rats with Glycerol-induced Acute Renal Failure.
Pharm. Res., 25 (10), 2243-2249 (2008 Oct).
31)
Naomi Iihara, Yuji Kurosaki, Chika Miyoshi, Kiyo Takabatake and Shushi
Morita:
Changes in attitudes among Japanese patients after Pharmacist Law revision.
Pharmacy World Sci., 30 (3), 258-264 (2008 Jun).
30)
Zen-ichi Masuda, Yuji Kurosaki, Kozo Ishino, Keita Yamauchi, Shunji Sano:
Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration.
General Thoracic Cardiovasular Surgery, 56 (4), 163-169 (2008 Apr).
29)
Satoshi Ueshima, Tetsuya Aiba, Takashi Makita, Shigeki Nishihara, Yoshihisa
Kitamura, Yuji Kurosaki, Hiromu Kawasaki, Toshiaki Sendo, Yoko Ohtsuka
and Yutaka Gomita:
Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
J. Clin. Pharm. Ther., 33 (1), 31-38 (2008 Feb).
28)
Naomi Iihara, Yuji Kurosaki, Chika Miyoshi, Kiyo Takabatake, Shushi Morita
and Keizo Hori:
Comparison of individual perceptions of medication costs and benefits
between intentional and unintentional medication non-adherence among
Japanese patients.
Patient Education Counseling, 70 (2), 292-299, (2008 Feb).
27)
Naomi Iihara, Yuji Kurosaki, Mitsutaka Takada and Shushi Morita:
Risk of hypoglycemia associated with thyroid agents is increased in patients with liver impairment.
Int. J. Clin. Pharmacol. Ther., 46 (1), 1-13, (2008 Jan).
y2007z
26)
Yukiko Komori, Tetsuya Aiba, Chie Nakai, Risa Sugiyama, Hiromu Kawasaki and Yuji Kurosaki:
Capsaicin-induced increase of intestinal cefazolin absorption in rats.
Drug Metabol. Pharmacokinet., 22 (6), 445-449 (2007 Dec).
25)
Hidekatsu Nishimura, Chiaki Hayashi, Tetsuya Aiba, Ichiro Okamoto, Yuji
Miyamoto, Susumu Nakade, Kazuhisa Takeda, Yuji Kurosaki:
Application of the correlation of in vitro dissolution behavior and in vivo plasma concentration profile (IVIVC) for soft-gel capsules | A pointless pursuit?
Biol. Pharm. Bull., 30 (11), 2221-2225 (2007 Nov).
24)
Yuji Kurosaki, Masahiro Tagawa, Akiho Omoto, Hiroshi Suito, Yukiko Komori,
Hiromu Kawasaki and Tetsuya Aiba:
Evaluation of intramuscular lateral distribution profile of topically administered acetaminophen in rats.
Int. J. Pharm., 343 (1-2), 190-195 (2007 Oct).
22)
Yukiko Komori, Tetsuya Aiba, Risa Sugiyama, Chie Nakai, Hiromu Kawasaki
and Yuji Kurosaki:
Effect of capsaicin on intestinal cephalexin absorption in rats.
Biol. Pharm. Bull., 30 (3), 547-551 (2007 Apr).
21)
Yukiko Komori, Tetsuya Aiba, Miki Kushima, Hiromu Kawasaki and Yuji Kurosaki:
Alteration of therapeutic efficacy of lipid microspheres incorporating prostaglandin E1 by mixing with aqueous solution.
J. Pharm. Sci., 96 (4), 935-943 (2007 Mar).
yOther significant reports (2001-2006)z
Tetsuya Aiba, Mizuki Horiuchi, Takashi Makita, Yukiko Komori, Hiromu Kawasaki
and Yuji Kurosaki:
Peritoneal dialysis alters tolbutamide pharmacokinetics in rats with experimental acute renal failure.
Drug Metabol. Pharmacokinet., 21 (4), 291-296 (2006 Aug).
Hiroo Maeda, Toshihiko Sugie, Akihiko Sano, Hiromu Kawasaki and Yuji Kurosaki:
Study on accelerated evaluation system for release profiles of covered-rod type silicone formulation using indomethacin as a model drug.
J. Controlled Release, 94 (3), 337-349 (2004 Feb).
Hiroo Maeda, Erika Ohashi, Akihisa Sano, Hiromu Kawasaki and Yuji Kurosaki:
Investigation of release behavior of covered-rod type formulation using silicone.
J. Controlled Release, 90 (1), 59-70 (2003 Jun).
Keita Yamauchi, Shoji Yasunaga, Hiromu Kawasaki and Yuji Kurosaki:
An approach to predict the ductus-arteriosus dilating effect induced by lipo-prostaglandin E1 in newborn rats lacking plasma concentration-time data by the pharmacological response kinetic model.
Biol. Pharm. Bull., 26 (2), 210-215 (2003 Feb).